First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
=========================================================================================================================================================================================================

* Rom Leidner
* Kevin Conlon
* Douglas G McNeel
* Andrea Wang-Gillam
* Sumati Gupta
* Robert Wesolowski
* Monica Chaudhari
* Nadia Hassounah
* Jong Bong Lee
* Lang Ho Lee
* Jessica A O’Keeffe
* Nancy Lewis
* George N Pavlakis
* John A Thompson